SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001113148-21-000026
Filing Date
2021-12-10
Accepted
2021-12-10 08:00:34
Documents
14
Period of Report
2021-12-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K infi-20211210.htm   iXBRL 8-K 41043
2 EX-99.1 ex991pr121020218-ksabcs.htm EX-99.1 26221
6 GRAPHIC headera03.jpg GRAPHIC 24003
  Complete submission text file 0001113148-21-000026.txt   247719

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20211210.xsd EX-101.SCH 1890
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20211210_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20211210_pre.xml EX-101.PRE 13038
7 EXTRACTED XBRL INSTANCE DOCUMENT infi-20211210_htm.xml XML 11559
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 211483694
SIC: 2834 Pharmaceutical Preparations